Xponance’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
VPM
RP
VCM
Xponance's ACLS Position: Q1 2026 in Review
Xponance increased its Axcelis (ACLS) stake by 16% in Q1 2026, buying an estimated $35.1K and bringing the position to 2,940 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #1323.
Xponance first reported a position in ACLS in Q1 2023 and has held it in 10 quarters since. The position peaked at $351K in Q2 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- Xponance held 2,940 shares of Axcelis worth $274K as of Q1 2026.
- Xponance bought 396 Axcelis shares in Q1 2026, an estimated $35.1K.
- Axcelis made up ﹤0.01% of Xponance's portfolio in Q1 2026, its #1323 holding.
- Xponance first reported a position in Axcelis in Q1 2023 and has held it in 10 quarters since.
- Xponance's Axcelis position peaked at $351K in Q2 2023.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.